Vicebio

Vicebio

We are committed to developing highly innovative and effective vaccines to target life-threatening respiratory viral infectious diseases.

HQ location
London, United Kingdom
Launch date
Employees
Enterprise value
$400—600m
Company register number
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

$100m

Series B
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads